Q1 2025 Holdings
Filed 2025-05-15 | 37 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $317.3M | 8,493,321 | 27.0% |
| Metsera Inc | COM | 59267L107 | $102.1M | 3,750,662 | 8.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $93.5M | 12,762,462 | 8.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $79.2M | 4,026,331 | 6.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $77.4M | 6,703,985 | 6.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $52.3M | 3,882,709 | 4.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $48.9M | 3,112,720 | 4.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $43.3M | 2,685,448 | 3.7% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $42.6M | 4,148,428 | 3.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $37.5M | 989,985 | 3.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $34.0M | 5,684,411 | 2.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $31.6M | 1,744,373 | 2.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $22.7M | 2,173,913 | 1.9% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $22.6M | 1,051,518 | 1.9% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $22.6M | 5,046,414 | 1.9% |
| Erasca Inc(ERAS) | COM | 29479A108 | $22.2M | 16,216,216 | 1.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $17.8M | 3,182,527 | 1.5% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $14.0M | 2,295,319 | 1.2% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $13.1M | 2,457,348 | 1.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $10.4M | 1,379,965 | 0.9% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $9.2M | 2,481,400 | 0.8% |
| Savara Inc(SVRA) | COM | 805111101 | $9.0M | 3,257,639 | 0.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $8.4M | 1,345,780 | 0.7% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.7M | 750,000 | 0.7% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $7.4M | 632,931 | 0.6% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $6.5M | 5,023,166 | 0.6% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $4.8M | 1,609,569 | 0.4% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.9M | 615,506 | 0.3% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $2.7M | 5,567,709 | 0.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $2.2M | 677,600 | 0.2% |
| Casi Pharmaceuticals Inc(CASIF) | ORD SHS | G1933S101 | $2.1M | 987,259 | 0.2% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $1.4M | 208,333 | 0.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $1.2M | 3,574,325 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $1.2M | 2,498,069 | 0.1% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $886.8K | 1,555,556 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $630.0K | 3,000,000 | 0.1% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $576.0K | 33,177 | 0.0% |